Role of Photodynamic Therapy in the Palliation of Obstructing Esophageal Cancer
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: The aim of this non-randomized study was to determine the role of photodynamic therapy (PDT) in a multimodal approach for the palliation of advanced esophageal carcinoma. Methods: Twenty consecutive patients with obstructing esophageal cancer were enrolled in this study. Each subject had dysphagia, and nine could not swallow fluid. External beam radiotherapy or a self-expandable metal stent was used following PDT for dysphagia due to recurrence of the malignancy. Results: At 4 weeks post-PDT, a significant improvement in the dysphagia score was observed in 90% of patients, from 2.75 ± 0.91 to 1.05 ± 0.83 (p < 0.05). Patients with recurrent dysphagia underwent stent insertion at an average of 63 days (range, 37 to 90). The rate of major complications was 10%. Two esophageal strictures occurred, which were treated by placement of a modified expandable stent across the stricture. The median survival in these cases was 7.0 ± 0.6 months. One patient that was treated with PDT and radiotherapy is alive and showed a complete tumor response. Conclusions: PDT as a multimodality treatment is safe and effective for relieving malignant esophageal obstruction with minimal complications.
Abstract
Background/Aims: The aim of this non-randomized study was to determine the role of photodynamic therapy (PDT) in a multimodal approach for the palliation of advanced esophageal carcinoma. Methods: Twenty consecutive patients with obstructing esophageal cancer were enrolled in this study. Each subject had dysphagia, and nine could not swallow fluid. External beam radiotherapy or a self-expandable metal stent was used following PDT for dysphagia due to recurrence of the malignancy. Results: At 4 weeks post-PDT, a significant improvement in the dysphagia score was observed in 90% of patients, from 2.75 ± 0.91 to 1.05 ± 0.83 (p < 0.05). Patients with recurrent dysphagia underwent stent insertion at an average of 63 days (range, 37 to 90). The rate of major complications was 10%. Two esophageal strictures occurred, which were treated by placement of a modified expandable stent across the stricture. The median survival in these cases was 7.0 ± 0.6 months. One patient that was treated with PDT and radiotherapy is alive and showed a complete tumor response. Conclusions: PDT as a multimodality treatment is safe and effective for relieving malignant esophageal obstruction with minimal complications.
참고문헌 (20)
- Sharpe DA, "Resectional surgery in carcinoma of the oesophagus and cardia: what influences long-term survival?", Eur J Cardiothorac Surg, 10, pp.359~363 (1996)
- Muller JM, "Surgical therapy of oesophageal carcinoma", Br J Surg, 77, pp.845~857 (1990)
- Blot WJ, "Esophageal cancer trends and risk factors", Semin Oncol, 21, pp.403~410 (1994)
- Parker CH, "Palliative treatment of esophageal carcinoma using esophageal dilation and prosthesis", Gastroenterol Clin North Am, 20, pp.717~729 (1991)
- Kim CM, "A retrospective study on radiotherapy and radiochemotherapy in esophageal cancer", Korean J Intern Med, 3, pp.58~63 (1988)
- Rupinski M, "Randomized comparison of three palliative regimens including brachytherapy, photodynamic therapy, and APC in patients with malignant dysphagia (CONSORT 1a) (Revised II)", Am J Gastroenterol, 106, pp.1612~1620 (2011)
- Knyrim K, "A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer", N Engl J Med, 329, pp.1302~1307 (1993)
- Pantling AZ, "Outcomes from chemoradiotherapy for patients with esophageal cancer", Dis Esophagus, 24, pp.172~176 (2011)
- Yano T, "Long-term results of salvage photodynamic therapy for patients with local failure after chemoradiotherapy for esophageal squamous cell carcinoma", Endoscopy, 43, pp.657~663 (2011)
- Lightdale CJ, "Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial", Gastrointest Endosc, 42, pp.507~512 (1995)
- McCaughan JS, "Photody namic therapy for obstructive esophageal malignancies", Diagn Ther Endosc, 5, pp.167~174 (1999)
- Shim CS, "Fixation of a modified covered esophageal stent: its clinical usefulness for preventing stent migration", Endoscopy, 33, pp.843~848 (2001)
- Tanaka T, "Photodynamic therapy for large superficial squamous cell carcinoma of the esophagus", Gastrointest Endosc, 73, pp.1~6 (2011)
- Grosjean P, "Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II", Br J Cancer, 77, pp.1989~1995 (1998)
- 천영국, "Outcome of Photodynamic Therapy for Early Esophageal Cancer", Gut and Liver, 1(2), pp.126~131 (2007), 거트앤리버 발행위원회
- Maier A, "Palliation of advanced esophageal carcinoma by photodynamic therapy and irradiation", Ann Thorac Surg, 69, pp.1006~1009 (2000)
- Tytgat GN, "Endoscopic therapy of esophageal cancer: possibilities and limitations", Endoscopy, 22, pp.263~267 (1990)
- Ell C, "Self-expanding metal stents for palliation of stenosing tumors of the esophagus and cardia: a critical review", Endoscopy, 29, pp.392~398 (1997)
- Likier HM, "Photodynamic therapy for completely obstructing esophageal carcinoma", Gastrointest Endosc, 37, pp.75~78 (1991)
- Luketich JD, "Endoscopic photodynamic therapy for obstructing esophageal cancer: 77 cases over a 2-year period", Surg Endosc, 14, pp.653~657 (2000)